tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
XERS is currently covered by 3 analysts with an average price target of $12.84. This is a potential upside of $3.63 (39.41%) from yesterday's end of day stock price of $9.21.
Xeris Pharmaceuticals's activity chart (see below) currently has 46 price targets and 37 ratings on display. The stock rating distribution of XERS is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 70.83% with an average time for these price targets to be met of 543.38 days.
Highest price target for XERS is $8, Lowest price target is $4, average price target is $6.33.
Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 08-May-2025. First documented stock forecast 15-Jul-2018.
Currently out of the existing stock ratings of XERS, 2 are a HOLD (33.33%), 4 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$7
$-2.21 (-24.00%)
$6
5 months 17 days ago
(08-May-2025)
3/3 (100%)
$1.99 (39.72%)
201
Buy
$8
$-1.21 (-13.14%)
$6.6
7 months 19 days ago
(06-Mar-2025)
12/12 (100%)
$3.76 (88.68%)
698
Hold
$4
$-5.21 (-56.57%)
$3
7 months 19 days ago
(06-Mar-2025)
4/4 (100%)
$-0.24 (-5.66%)
170
Buy
$4.5
$2.06 (84.43%)
$6.5
2 years 1 months 28 days ago
(28-Aug-2023)
0/2 (0%)
$2.23 (98.24%)
Buy
$6
$-3.21 (-34.85%)
3 years 7 months 10 days ago
(15-Mar-2022)
1/1 (100%)
$3.21 (115.05%)
1240
What is XERS (Xeris Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on XERS (Xeris Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on XERS (Xeris Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on XERS (Xeris Pharmaceuticals)?
Which analyst is the currently most bullish on XERS (Xeris Pharmaceuticals)?
Which analyst is the currently most reserved on XERS (Xeris Pharmaceuticals)?
